Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Tandem Meetings 2023 | Increasing access to survivorship care for CAR-T recipients

Nausheen Ahmed • 20 Feb 2023
Tandem Meetings 2023
General CAR-T

Nausheen Ahmed, MD, University of Kansas Medical Center, Westwood, KS, outlines strategies to grow survivorship programs for patients treated with CAR-T therapy. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

BMS: Advisory Board; KUMC – Kite Pharma: Research Funding

More from Nausheen Ahmed

Addressing disparities in access to CAR-T therapy for hematological malignancies
1:18
Addressing disparities in access to CAR-T therapy for hematological malignancies
Nausheen Ahmed • 9 Jun 2023
Outcomes of outpatient tisa-cel recipients with B-NHL
0:47
Outcomes of outpatient tisa-cel recipients with B-NHL
Nausheen Ahmed • 9 Jun 2023
Exploring the role of CAR-T therapy in MCL & impact of prior treatment with BTKi or bendamustine
1:06
Exploring the role of CAR-T therapy in MCL & impact of prior treatment with BTKi or bendamustine
Nausheen Ahmed • 9 Jun 2023
Real-world outcomes of brexu-cel in patients with R/R MCL
0:47
Real-world outcomes of brexu-cel in patients with R/R MCL
Nausheen Ahmed • 9 Jun 2023

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals